Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Total revenues	$ 7,370	$ 6,756
Total cost of revenues	(5,325)	(4,919)
Gross profit	2,045	1,837
Selling, general and administrative expenses	(2,057)	(1,833)
Gain on disposal of long-lived assets	22	14
Loss on impairments	(48)	0
Operating (loss) income	(38)	18
Interest income	21	37
Interest expense	(203)	(181)
Other nonoperating expense, net	(4)	(20)
Loss from operations before income tax benefit and loss from equity method investments	(224)	(146)
Income tax benefit	55	58
Loss from equity method investments	(11)	(10)
Net loss	(180)	(98)
Net loss attributable to noncontrolling interests	4	4
Net loss attributable to CRH	$ (176)	$ (94)
Loss per share attributable to CRH
Basic (in USD per share)	$ (0.27)	$ (0.15)
Diluted (in USD per share)	$ (0.27)	$ (0.15)
Weighted average common shares outstanding
Basic (in shares)	668.5	676.7
Diluted (in shares)	668.5	676.7
Product
Total revenues	$ 6,234	$ 5,612
Total cost of revenues	(4,251)	(3,826)
Service
Total revenues	1,136	1,144
Total cost of revenues	$ (1,074)	$ (1,093)